The challenge of omalizumab refractory chronic spontaneous urticaria and the relevance of suspecting Schnitzler syndrome without monoclonal gammopathy

ABSTRACT Introduction: Schnitzler syndrome (SchS) is a rare autoinflammatory syndrome characterized by chronic urticaria and monoclonal gammopathy (MG). Clinical cases without monoclonal gammopathy have been recorded. Clinical Case: We report on the case of a 43-year-old female with chronic spontaneous urticaria refractory to omalizumab (OMZ) despite a dosage increase (600 mg/4 weeks). Additionally, she developed asthenia and episodes of arthralgias and fever predominantly in the evening. Laboratory re-evaluation revealed elevated inflammatory parameters and skin biopsy showed neutrophilic infiltration. Although MG was absent, SchS was the most likely diagnosis, as other differential diagnoses were excluded. Treatment was started with anakinra, with complete resolution of symptoms. Conclusion: We highlight the importance of specialized urticaria clinics and of reassessing the diagnosis in patients with refractory chronic urticaria. An autoinflammatory disease, such as SchS, could be the diagnosis, even without the presence of monoclonal gammopathy.

Saved in:
Bibliographic Details
Main Authors: Paulino,Marisa, Costa,Célia
Format: Digital revista
Language:English
Published: Sociedade Portuguesa de Alergologia e Imunologia Clínica 2023
Online Access:http://scielo.pt/scielo.php?script=sci_arttext&pid=S0871-97212023000300227
Tags: Add Tag
No Tags, Be the first to tag this record!
id oai:scielo:S0871-97212023000300227
record_format ojs
spelling oai:scielo:S0871-972120230003002272023-10-23The challenge of omalizumab refractory chronic spontaneous urticaria and the relevance of suspecting Schnitzler syndrome without monoclonal gammopathyPaulino,MarisaCosta,Célia Autoinflammatory syndromes chronic urticaria schnitzler syndrome urticaria ABSTRACT Introduction: Schnitzler syndrome (SchS) is a rare autoinflammatory syndrome characterized by chronic urticaria and monoclonal gammopathy (MG). Clinical cases without monoclonal gammopathy have been recorded. Clinical Case: We report on the case of a 43-year-old female with chronic spontaneous urticaria refractory to omalizumab (OMZ) despite a dosage increase (600 mg/4 weeks). Additionally, she developed asthenia and episodes of arthralgias and fever predominantly in the evening. Laboratory re-evaluation revealed elevated inflammatory parameters and skin biopsy showed neutrophilic infiltration. Although MG was absent, SchS was the most likely diagnosis, as other differential diagnoses were excluded. Treatment was started with anakinra, with complete resolution of symptoms. Conclusion: We highlight the importance of specialized urticaria clinics and of reassessing the diagnosis in patients with refractory chronic urticaria. An autoinflammatory disease, such as SchS, could be the diagnosis, even without the presence of monoclonal gammopathy.info:eu-repo/semantics/openAccessSociedade Portuguesa de Alergologia e Imunologia ClínicaRevista Portuguesa de Imunoalergologia v.31 n.3 20232023-09-01info:eu-repo/semantics/reporttext/htmlhttp://scielo.pt/scielo.php?script=sci_arttext&pid=S0871-97212023000300227en10.32932/rpia.2023.08.119
institution SCIELO
collection OJS
country Portugal
countrycode PT
component Revista
access En linea
databasecode rev-scielo-pt
tag revista
region Europa del Sur
libraryname SciELO
language English
format Digital
author Paulino,Marisa
Costa,Célia
spellingShingle Paulino,Marisa
Costa,Célia
The challenge of omalizumab refractory chronic spontaneous urticaria and the relevance of suspecting Schnitzler syndrome without monoclonal gammopathy
author_facet Paulino,Marisa
Costa,Célia
author_sort Paulino,Marisa
title The challenge of omalizumab refractory chronic spontaneous urticaria and the relevance of suspecting Schnitzler syndrome without monoclonal gammopathy
title_short The challenge of omalizumab refractory chronic spontaneous urticaria and the relevance of suspecting Schnitzler syndrome without monoclonal gammopathy
title_full The challenge of omalizumab refractory chronic spontaneous urticaria and the relevance of suspecting Schnitzler syndrome without monoclonal gammopathy
title_fullStr The challenge of omalizumab refractory chronic spontaneous urticaria and the relevance of suspecting Schnitzler syndrome without monoclonal gammopathy
title_full_unstemmed The challenge of omalizumab refractory chronic spontaneous urticaria and the relevance of suspecting Schnitzler syndrome without monoclonal gammopathy
title_sort challenge of omalizumab refractory chronic spontaneous urticaria and the relevance of suspecting schnitzler syndrome without monoclonal gammopathy
description ABSTRACT Introduction: Schnitzler syndrome (SchS) is a rare autoinflammatory syndrome characterized by chronic urticaria and monoclonal gammopathy (MG). Clinical cases without monoclonal gammopathy have been recorded. Clinical Case: We report on the case of a 43-year-old female with chronic spontaneous urticaria refractory to omalizumab (OMZ) despite a dosage increase (600 mg/4 weeks). Additionally, she developed asthenia and episodes of arthralgias and fever predominantly in the evening. Laboratory re-evaluation revealed elevated inflammatory parameters and skin biopsy showed neutrophilic infiltration. Although MG was absent, SchS was the most likely diagnosis, as other differential diagnoses were excluded. Treatment was started with anakinra, with complete resolution of symptoms. Conclusion: We highlight the importance of specialized urticaria clinics and of reassessing the diagnosis in patients with refractory chronic urticaria. An autoinflammatory disease, such as SchS, could be the diagnosis, even without the presence of monoclonal gammopathy.
publisher Sociedade Portuguesa de Alergologia e Imunologia Clínica
publishDate 2023
url http://scielo.pt/scielo.php?script=sci_arttext&pid=S0871-97212023000300227
work_keys_str_mv AT paulinomarisa thechallengeofomalizumabrefractorychronicspontaneousurticariaandtherelevanceofsuspectingschnitzlersyndromewithoutmonoclonalgammopathy
AT costacelia thechallengeofomalizumabrefractorychronicspontaneousurticariaandtherelevanceofsuspectingschnitzlersyndromewithoutmonoclonalgammopathy
AT paulinomarisa challengeofomalizumabrefractorychronicspontaneousurticariaandtherelevanceofsuspectingschnitzlersyndromewithoutmonoclonalgammopathy
AT costacelia challengeofomalizumabrefractorychronicspontaneousurticariaandtherelevanceofsuspectingschnitzlersyndromewithoutmonoclonalgammopathy
_version_ 1787237071285387264